DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status
[Background] Changas disease is caused by the protozoan Trypanosoma cruzi and is characterized by heart failure and sudden death. Identifying which factors are involved in evolution and treatment response is actually challenging.
Thus, the aim of this work was to determine the Th1/Th17 (IL-6, IL-2, TNF, IL-17 and IFN-γ) and Th2 (IL-4 and IL-10) serum profile in Venezuelan Chagasic patients stratified according amiodarone treatment, hypertension and arrhythmias., [Methods]
Sera from 38 chagasic patients were analyzed to determine the level of cytokines by Multiplexed Bead-Based Immunoassays. ANOVA test was applied to determine differences for each group. Additionally, a Linear Discriminant Analysis (LDA) was applied to observe the accuracy of different cytokines to discriminate between the groups., [Results]
The levels of several cytokines were significantly higher in the high-risk of sudden death and untreated group. LDA showed that IL-2, IFN-γ and IL-10 were the best cytokines for discriminating between high-risk of sudden death and untreated patients versus low-risk of sudden death, treated and control groups., [Conclusions]
High IL-2 levels seem to identify patients with high-risk of sudden death and seems adequate as treatment efficacy marker. To our knowledge, this is the first report about the anti-inflammatory role of the amiodarone in Chagas disease, suggesting an inmunomodulatory effect that may be exploited as coadjutant therapy in chronic Chagas disease., This work was supported by MF grant (SN/2013) and NG grant (CEAL-AL/2015-12) from “UAM-Banco Santander” for collaboration with Latin America; by NG grants from “Fondo de Investigaciones Sanitarias/FEDER” (PS09/00538 and PI12/00289), MINECO/FEDER (SAF2015-63868-R) “Universidad Autónoma de Madrid” and “Comunidad de Madrid” (CC08-UAM/SAL-4440/08); by MF grants from “Ministerio de Ciencia e Innovación” (SAF2010-17833 and SAF2013-42850-R), MINECO/FEDER (SAF2016-75998-R), “Red de Investigación de Centros de Enfermedades Tropicales” (RICET RD12/0018/0004; RICET RD16/0027/0006); European Union (HEALTH-FE-2008-22303, ChagasEpiNet, HOMIN - 317057 - FP7-PEOPLE-2012-ITN); AECID (A/025417/09 and A/031735/10), Comunidad de Madrid (S-2010/BMD-2332), Proyecto Excelencia BIOIMID - IIS La Princesa and “Fundación Ramón Areces”; and by HR and AM grants from Instituto Venezolano de Investigaciones Científicas (IVIC-1365)., Peer reviewed